FDA 1998 NME APPROVALS COULD FEATURE UP TO 10 NEW NEUROPHARM PRODUCTS; FDA APPROVES 39 NMEs IN 1997 IN AVERAGE OF 17 MONTHS, MAKING 92 NMEs IN TWO YEARS
Executive Summary
FDA's 1998 new molecular entity approvals could feature up to 10 neuropharmacological drugs on top of the five NMEs approved in the neuropharm area in 1997.